LL-37 5 mg
$70.00
Dragon Pharma LL-37 5 mg – Natural Human Antimicrobial Peptide for Immune Research
Dragon Pharma LL-37 5 mg is a natural human antimicrobial peptide derived from the cathelicidin protein. Consisting of 37 amino acids, LL-37 serves as a critical component of the innate immune system, acting as a first-line defense against microbial pathogens and playing important roles in wound healing and inflammation regulation.
Each vial contains 5 mg of lyophilized LL-37 in a 2 mL format, requiring reconstitution with bacteriostatic water before use. This peptide has been extensively studied for its broad-spectrum antimicrobial activity against bacteria, viruses, and fungi, as well as its immunomodulatory properties and ability to promote wound healing. For related research compounds, explore our peptides category and specifically BPC 157 for complementary tissue repair research applications.
What Makes LL-37 Valuable in Research?
LL-37 is one of the most well-characterized antimicrobial peptides in the human immune system. It demonstrates a unique dual function: direct antimicrobial activity through membrane disruption and immunomodulatory effects that influence host immune responses. Its ability to neutralize endotoxins, modulate inflammatory cytokine production, and promote epithelial cell migration makes it a valuable tool for studying innate immunity and tissue repair.
Researchers value LL-37 for its broad-spectrum activity and its role in connecting innate and adaptive immune responses. Its involvement in wound healing, angiogenesis, and chemotaxis makes it relevant to studies ranging from infectious disease to tissue regeneration. For investigators exploring other immune-modulating compounds, Thymosin Alpha-1 offers complementary research avenues in immune system regulation.
Current scientific literature on LL-37 can be accessed through the PubMed database, where researchers can review peer-reviewed studies on its biological activity and experimental applications.
Key Research Applications for Dragon Pharma LL-37
- ✔ Investigation of antimicrobial mechanisms against pathogens
- ✔ Evaluation of immunomodulatory and anti-inflammatory effects
- ✔ Research on wound healing and tissue regeneration
- ✔ Studies of innate immune system function and regulation
- ✔ Preclinical models of infection and inflammation
LL-37 5 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on wound healing, TB 500 provides additional research avenues in tissue repair and angiogenesis.